This is achieved in two key ways
Pancreatitis: Case studies and a few of the clinical trials on GLP-1 RAs for diabetes have raised the possibility of pancreatitis being triggered by these drugs due to the potential growth in cells in the pancreas
A lack of Akkermansia is often found in individuals who struggle with persistent food noise and metabolic resistance
Type 2 diabetes mellitus (T2DM) affects the majority of people with diabetes, accounting for more than 90% of those with diabetes, and is characterized by insulin secretion defects in pancreatic -cells and insulin resistance, whereas type 1 DM is caused by autoreactive T cell-mediated destruction of -cells ( Figure 1 ) ( Figure 1 Consequently, this results in the redundant stimulation of the unaffected RAS-MAPK pathway (mitogenic arm) of insulin signaling, contributing to cardiovascular dysfunction and endothelial injury and advancing myriads of chronic diabetic complications by significantly compromising the quality of life ( Role of incretin hormones The insulinotropic effects of incretin hormones are the reason why the body produces more insulin in response to meals when glucose is ingested orally rather than when it is administered intravenously, even when the plasma glucose levels are the same
China has the world's largest diabetes population, with approximately 148 million adults living with diabetes according to the International Diabetes Federation, creating substantial demand for long-acting GLP-1 therapies and obesity-management solutions
